Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences is engaged in the development of drugs for the treatment of neurological and endocrine-related diseases.
Founded
1992
Raised
$10M
Follow us
Alexa global traffic share
Latest funding
$10,000,000
Venture capital - 2009
Team Size
1–10
Employees
neurons.AI

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize …

the home of AI info

Neurocrine Biosciences (NBIX) – Research Analysts' Recent Ratings Updates

the home of AI info

Neurocrine Biosciences and Xenon Launch Up-to-$1.7B Epilepsy, Neuroscience Collaboration

the home of AI info

Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to “Buy” at Zacks Investment Research

The Motley Fool

Why Neurocrine Biosciences Inc.'s Stock Skyrocketed 147% Higher in 2015 --

Stock markets